Internal Neuromodulation Devices Global Market Opportunities And Strategies To 2034

Description

Internal neuromodulation devices are implantable medical devices designed to deliver targeted electrical or chemical stimulation to specific nerves, spinal pathways, or brain regions, thereby modulating abnormal neural activity. These devices are placed inside the body to treat chronic pain, movement disorders, epilepsy, and other neurological or physiological conditions. The primary purpose of internal neuromodulation devices is to restore or regulate neural function in patients with conditions that do not respond adequately to conventional therapies.

The global internal neuromodulation devices market reached a value of nearly $2,594.6 million in 2024, having grown at a compound annual growth rate (CAGR) of 6.3% since 2019. The market is expected to grow from $2,594.6 million in 2024 to $4,046.6 million in 2029 at a rate of 9.3%. The market is then expected to grow at a CAGR of 8.1% from 2029 and reach $5,966.7 million in 2034.

Rising Prevalence Of Chronic Pain Disorders

During the historic period, the internal neuromodulation devices market was driven by the rising prevalence of chronic pain disorders. As chronic pain became more widespread, limitations of long-term pharmacological management, including declining effectiveness, side effects, and dependency concerns, pushed clinicians and patients to seek durable, device-based solutions. Internal neuromodulation systems, particularly spinal cord stimulators, gained traction as they offered targeted, adjustable, and sustained therapeutic effects for individuals living with persistent pain. For instance, in November 2024, according to the US Centers for Disease Control and Prevention (CDC), a US-based National Center for Health Statistics, in 2023 National Health Interview Survey, 24.3% of US adults (about 1 in 4) reported chronic pain in the past 3 months and 8.5% reported high-impact chronic pain that frequently limited life or work activities. The same report noted that this represented an increase from 20.4% with chronic pain and 7.4% with high-impact chronic pain in 2019, illustrating a rising burden of chronic pain disorders over time Therefore, the internal neuromodulation devices market was driven by the rising prevalence of chronic pain disorders.

Focus On MRI-Compatible VNS Platforms For Epilepsy And New Indications

Major companies in the internal neuromodulation devices market are increasingly emphasizing the development and regulatory introduction of implantable Vagus Nerve Stimulation System (VNS) platforms that are MRI (magnetic resonance imaging)-compatible and cleared for newer therapeutic indications beyond classic epilepsy or depression. This trend aims to make VNS therapy more patient-friendly, by enabling safe access to MRI imaging when needed, and by expanding the use of VNS for chronic neurological or inflammatory diseases. For example, in August 2025, SetPoint Medical, a US-based company develops bioelectronic therapies, newly developed implantable VNS device, SetPoint System, was approved by the US Food and Drug Administration (FDA) for use in adults with moderate-to-severe Rheumatoid Arthritis (RA) who had failed conventional therapies. This represents a meaningful expansion of clinical use for VNS beyond neurological disorders. This shows how VNS technology is evolving, not just on the hardware front (implantable, MRI-compatible), but also in therapeutic positioning, aligning neuromodulation with chronic disease management beyond neurology.

The global internal neuromodulation devices market is fairly fragmented, with large number of small players operating in the market. The top ten competitors in the market made up to 34.2% of the total market in 2024.

Internal Neuromodulation Devices Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global internal neuromodulation devices market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for internal neuromodulation devices? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The internal neuromodulation devices market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider internal neuromodulation devices market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics: - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by biomaterial, by application and by end-user.
Key Trends: - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Growth Analysis And Strategic Analysis Framework: - Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
Global Market Size And Growth: - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis: - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation: - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by biomaterial, by application and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size And Growth: - Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape: - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies: - Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking: - Briefs on the financials comparison between major players in the market.
Competitive Dashboard: - Briefs on competitive dashboard of major players.
Key Mergers And Acquisitions: - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Recent Developments: - Information on recent developments in the market covered in the report
Market Opportunities And Strategies Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations This section includes recommendations for internal neuromodulation devices providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix: - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Type: Spinal Cord Stimulator; Deep Brain Stimulator; Sacral Nerve Stimulator; Vagus Nerve Stimulator; Gastric Neuro Stimulator
2) By Biomaterial: Metallic Biomaterials; Polymeric Biomaterials; Ceramic Biomaterials
3) By Application: Failed Back Surgery Syndrome; Parkinson's Disease; Urinary Incontinence; Epilepsy; Gastroparesis
4) By End-User: Hospitals; Clinics; Home Healthcare; Community Healthcare
Companies Mentioned: Medtronic plc; Abbott Laboratoriesl; Boston Scientific Corporation; LivaNova plc; Nevro Corp
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; internal neuromodulation devices comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes."

Product Code: ME3MINDE01_O25Q4

1 Executive Summary

1.1 Internal Neuromodulation Devices - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Internal Neuromodulation Devices Market Definition And Segmentations
6.4 Market Segmentation By Type
- 6.4.1 Spinal Cord Stimulator
- 6.4.2 Deep Brain Stimulator
- 6.4.3 Sacral Nerve Stimulator
- 6.4.4 Vagus Nerve Stimulator
- 6.4.5 Gastric Neuro Stimulator
6.5 Market Segmentation By Biomaterial
- 6.5.1 Metallic Biomaterials
- 6.5.2 Polymeric Biomaterials
- 6.5.3 Ceramic Biomaterials
6.6 Market Segmentation By Application
- 6.6.1 Failed Back Surgery Syndrome
- 6.6.2 Parkinson's Disease
- 6.6.3 Urinary Incontinence
- 6.6.4 Epilepsy
- 6.6.5 Gastroparesis
6.7 Market Segmentation By End-User
- 6.7.1 Hospitals
- 6.7.2 Clinics
- 6.7.3 Home Healthcare
- 6.7.4 Community Healthcare

7 Major Market Trends

7.1 Focus On MRI-Compatible VNS Platforms For Epilepsy And New Indications
7.2 Development Of Fully Implantable, Wireless SNM Systems For Incontinence Therapy
7.3 Expansion of Closed-Loop and AI-Enabled Internal Neuromodulation Systems
7.4 Integration Of Directional Leads For Precision Neuromodulation In Movement Disorders
7.5 Adoption Of Implantable Gastric Stimulation For Drug-Resistant Gastroparesis

8 Global Internal Neuromodulation Devices Growth Analysis And Strategic Analysis Framework

8.1 Global Internal Neuromodulation Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
- 8.1.1 Political
- 8.1.2 Economic
- 8.1.3 Social
- 8.1.4 Technological
- 8.1.5 Environmental
- 8.1.6 Legal
8.2 End Users of B2B Market
- 8.2.1 Hospitals
- 8.2.2 Clinics
- 8.2.3 Home Healthcare
- 8.2.4 Community Healthcare
8.3 Global Internal Neuromodulation Devices Market Size And Growth Analysis
8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
- 8.4.1 Market Drivers 2019 - 2024
- 8.4.2 Market Restraints 2019 - 2024
8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
8.6 Forecast Growth Contributors/Factors
- 8.6.1 Quantitative Growth Contributors
- 8.6.2 Drivers
- 8.6.3 Restraints
8.7 Global Internal Neuromodulation Devices Total Addressable Market (TAM)
- 8.7.1 TAM Comparison Analysis

9 Global Internal Neuromodulation Devices Market Segmentation

9.1 Global Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.2 Global Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.3 Global Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.4 Global Internal Neuromodulation Devices Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.5 Global Internal Neuromodulation Devices Market, Sub-Segmentation Of Spinal Cord Stimulator, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.6 Global Internal Neuromodulation Devices Market, Sub-Segmentation By Deep Brain Stimulator, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.7 Global Internal Neuromodulation Devices Market, Sub-Segmentation By Sacral Nerve Stimulator, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.8 Global Internal Neuromodulation Devices Market, Sub-Segmentation By Vagus Nerve Stimulator, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.9 Global Internal Neuromodulation Devices Market, Sub-Segmentation By Gastric Neuro Stimulator, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Internal Neuromodulation Devices Market, Regional and Country Analysis

10.1 Global Internal Neuromodulation Devices Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.2 Global Internal Neuromodulation Devices Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

11.1 Summary
11.2 Market Overview
- 11.2.1 Region Information
- 11.2.2 Market Information
- 11.2.3 Background Information
- 11.2.4 Government Initiatives
- 11.2.5 Regulations
- 11.2.6 Regulatory Bodies
- 11.2.7 Major Associations
- 11.2.8 Taxes Levied
- 11.2.9 Corporate Tax Structure
- 11.2.10 Investments
- 11.2.11 Major Companies
11.3 Asia Pacific Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.4 Asia Pacific Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.5 Asia Pacific Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.6 Asia-Pacific Internal Neuromodulation Devices Market: Country Analysis
11.7 China Market
11.8 Summary
11.9 Market Overview
- 11.9.1 Country Information
- 11.9.2 Market Information
- 11.9.3 Background Information
- 11.9.4 Government Initiatives
- 11.9.5 Regulations
- 11.9.6 Regulatory Bodies
- 11.9.7 Major Associations
- 11.9.8 Taxes Levied
- 11.9.9 Corporate Tax Structure
- 11.9.10 Major Companies
11.10 China Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.11 China Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.12 China Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.13 India Market
11.14 India Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.15 India Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.16 India Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.17 Japan Market
11.18 Summary
11.19 Market Overview
- 11.19.1 Country Information
- 11.19.2 Market Information
- 11.19.3 Background Information
- 11.19.4 Government Initiatives
- 11.19.5 Regulations
- 11.19.6 Regulatory Bodies
- 11.19.7 Major Associations
- 11.19.8 Taxes Levied
- 11.19.9 Corporate Tax Structure
- 11.19.10 Major Companies
11.20 Japan Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.21 Japan Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.22 Japan Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.23 Australia Market
11.24 Australia Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.25 Australia Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.26 Australia Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.27 Indonesia Market
11.28 Indonesia Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.29 Indonesia Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.30 Indonesia Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.31 South Korea Market
11.32 Summary
11.33 Market Overview
- 11.33.1 Country Information
- 11.33.2 Market Information
- 11.33.3 Background Information
- 11.33.4 Government Initiatives
- 11.33.5 Regulations
- 11.33.6 Regulatory Bodies
- 11.33.7 Major Associations
- 11.33.8 Taxes Levied
- 11.33.9 Corporate Tax Structure
- 11.33.10 Investments
- 11.33.11 Major Companies
11.34 South Korea Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.35 South Korea Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.36 South Korea Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

12.1 Summary
12.2 Market Overview
- 12.2.1 Region Information
- 12.2.2 Market Information
- 12.2.3 Background Information
- 12.2.4 Government Initiatives
- 12.2.5 Regulations
- 12.2.6 Regulatory Bodies
- 12.2.7 Major Associations
- 12.2.8 Taxes Levied
- 12.2.9 Corporate tax structure
- 12.2.10 Investments
- 12.2.11 Major Companies
12.3 Western Europe Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.4 Western Europe Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.5 Western Europe Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.6 Western Europe Internal Neuromodulation Devices Market: Country Analysis
12.7 UK Market
12.8 UK Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.9 UK Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.10 UK Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.11 Germany Market
12.12 Germany Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.13 Germany Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.14 Germany Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.15 France Market
12.16 France Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.17 France Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.18 France Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.19 Italy Market
12.20 Italy Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.21 Italy Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.22 Italy Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.23 Spain Market
12.24 Spain Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.25 Spain Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.26 Spain Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

13.1 Summary
13.2 Market Overview
- 13.2.1 Region Information
- 13.2.2 Market Information
- 13.2.3 Background Information
- 13.2.4 Government Initiatives
- 13.2.5 Regulations
- 13.2.6 Regulatory Bodies
- 13.2.7 Major Associations
- 13.2.8 Taxes Levied
- 13.2.9 Corporate Tax Structure
- 13.2.10 Major companies
13.3 Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.4 Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.5 Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.6 Eastern Europe Internal Neuromodulation Devices Market: Country Analysis
13.7 Russia Market
13.8 Russia Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.9 Russia Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.10 Russia Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

14.1 Summary
14.2 Market Overview
- 14.2.1 Region Information
- 14.2.2 Market Information
- 14.2.3 Background Information
- 14.2.4 Government Initiatives
- 14.2.5 Regulations
- 14.2.6 Regulatory Bodies
- 14.2.7 Major Associations
- 14.2.8 Taxes Levied
- 14.2.9 Corporate Tax Structure
- 14.2.10 Investments
- 14.2.11 Major Companies
14.3 North America Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.4 North America Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.5 North America Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.6 North America Internal Neuromodulation Devices Market: Country Analysis
14.7 USA Market
14.8 Summary
14.9 Market Overview
- 14.9.1 Country Information
- 14.9.2 Market Information
- 14.9.3 Background Information
- 14.9.4 Government Initiatives
- 14.9.5 Regulations
- 14.9.6 Regulatory Bodies
- 14.9.7 Major Associations
- 14.9.8 Taxes Levied
- 14.9.9 Corporate Tax Structure
- 14.9.10 Investments
- 14.9.11 Major Companies
14.10 USA Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.11 USA Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.12 USA Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.13 Canada Market
14.14 Summary
14.15 Market Overview
- 14.15.1 Country Information
- 14.15.2 Market Information
- 14.15.3 Background Information
- 14.15.4 Government Initiatives
- 14.15.5 Regulations
- 14.15.6 Regulatory Bodies
- 14.15.7 Major Associations
- 14.15.8 Taxes Levied
- 14.15.9 Corporate Tax Structure
- 14.15.10 Investments
- 14.15.11 Major Companies
14.16 Canada Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.17 Canada Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.18 Canada Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

15.1 Summary
15.2 Market Overview
- 15.2.1 Region Information
- 15.2.2 Market Information
- 15.2.3 Background Information
- 15.2.4 Government Initiatives
- 15.2.5 Regulations
- 15.2.6 Regulatory Bodies
- 15.2.7 Major Associations
- 15.2.8 Taxes Levied
- 15.2.9 Corporate Tax Structure
- 15.2.10 Major Companies
15.3 South America Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.4 South America Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.5 South America Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.6 South America Internal Neuromodulation Devices Market: Country Analysis
15.7 Brazil Market
15.8 Brazil Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.9 Brazil Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.10 Brazil Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

16.1 Summary
16.2 Market Overview
- 16.2.1 Region Information
- 16.2.2 Market Information
- 16.2.3 Background Information
- 16.2.4 Government Initiatives
- 16.2.5 Regulations
- 16.2.6 Regulatory Bodies
- 16.2.7 Major Associations
- 16.2.8 Taxes Levied
- 16.2.9 Corporate Tax Structure
- 16.2.10 Major Companies
16.3 Middle East Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.4 Middle East Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.5 Middle East Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

17.1 Summary
17.2 Market Overview
- 17.2.1 Region Information
- 17.2.2 Market Information
- 17.2.3 Background Information
- 17.2.4 Government Initiatives
- 17.2.5 Regulations
- 17.2.6 Regulatory Bodies
- 17.2.7 Major Associations
- 17.2.8 Taxes Levied
- 17.2.9 Corporate Tax Structure
- 17.2.10 Major Companies
17.3 Africa Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.4 Africa Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.5 Africa Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

18.1 Company Profiles
18.2 Medtronic Inc
- 18.2.1 Company Overview
- 18.2.2 Products And Services
- 18.2.3 Business Strategy
- 18.2.4 Financial Overview
18.3 Abbott Laboratories
- 18.3.1 Company Overview
- 18.3.2 Products And Services
- 18.3.3 Business Strategy
- 18.3.4 Financial Overview
18.4 Boston Scientific Corporation
- 18.4.1 Company Overview
- 18.4.2 Products And Services
- 18.4.3 Business Strategy
- 18.4.4 Financial Overview
18.5 LivaNova plc
- 18.5.1 Company Overview
- 18.5.2 Products And Services
- 18.5.3 Business Strategy
- 18.5.4 Financial Overview
18.6 Nevro Corp
- 18.6.1 Company Overview
- 18.6.2 Products And Services
- 18.6.3 Business Strategy
- 18.6.4 Financial Overview

19 Other Major And Innovative Companies

19.1 Axonics Inc.
- 19.1.1 Company Overview
- 19.1.2 Products And Services
19.2 NeuroPace Inc.
- 19.2.1 Company Overview
- 19.2.2 Products And Services
19.3 Biotronik SE & Co. KG
- 19.3.1 Company Overview
- 19.3.2 Products And Services
19.4 Beijing PINS Medical (PINS)
- 19.4.1 Company Overview
- 19.4.2 Products And Services
19.5 ONWARD Medical NV
- 19.5.1 Company Overview
- 19.5.2 Products And Services
19.6 Mainstay Medical International plc
- 19.6.1 Company Overview
- 19.6.2 Products And Services
19.7 Inspire Medical Systems Inc.
- 19.7.1 Company Overview
- 19.7.2 Products And Services
19.8 Synchron Inc.
- 19.8.1 Company Overview
- 19.8.2 Products And Services
19.9 Stimwave Technologies Incorporated
- 19.9.1 Company Overview
- 19.9.2 Products And Services
19.10 Blackrock Neurotech
- 19.10.1 Company Overview
- 19.10.2 Products And Services
19.11 INBRAIN Neuroelectronics (Inbrain)
- 19.11.1 Company Overview
- 19.11.2 Products And Services
19.12 Nuvectra Corporation
- 19.12.1 Company Overview
- 19.12.2 Products And Services
19.13 Aleva Neurotherapeutics SA
- 19.13.1 Company Overview
- 19.13.2 Products And Services
19.14 Second Sight Medical Products Inc.
- 19.14.1 Company Overview
- 19.14.2 Products And Services
19.15 Synapse Biomedical Inc.
- 19.15.1 Company Overview
- 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

22.1 Globus Medical Acquired Nevro Corp.
22.2 Boston Scientific Acquired Axonics Inc.

23 Recent Developments In Internal Neuromodulation Devices

23.1 Adaptive Closed-Loop Deep Brain Stimulator Gains Regulatory Approval For Parkinson's Therapy
23.2 Automated Programming Platform Approved To Simplify SCS Management

24 Opportunities And Strategies

24.1 Global Internal Neuromodulation Devices Market In 2029 - Countries Offering Most New Opportunities
24.2 Global Internal Neuromodulation Devices Market In 2029 - Segments Offering Most New Opportunities
24.3 Global Internal Neuromodulation Devices Market In 2029 - Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies

25 Internal Neuromodulation Devices Market, Conclusions And Recommendations

25.1 Conclusions
25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People

26 Appendix

26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer